DIFFERENTIAL DIAGNOSIS OF TERMINAL GLOMERULONEPHRITIS AND MALIGNANT HYPERTENSION. I. RENAL ASPECTS
Authors: A. C.  CORCORAN, IRVINE H.  PAGE
Journal: Annals of Internal Medicine (1944)

Article1 November 1944DIFFERENTIAL DIAGNOSIS OF TERMINAL GLOMERULONEPHRITIS AND MALIGNANT HYPERTENSION. I. RENAL ASPECTSA. C. CORCORAN, M.D., IRVINE H. PAGE, M.D., F.A.C.P.A. C. CORCORAN, M.D.Search for more papers by this author, IRVINE H. PAGE, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-21-5-747 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptDifferential diagnosis in patients showing severe renal damage from chronic glomerulonephritis on the one hand, and malignant hypertension on the other has always been difficult. At this stage the two conditions have in common the clinical pattern of hypertension, loss of weight, anemia, so-called "albuminuric retinitis," depressed renal function, azotemia, proteinuria and increased organized urinary sediment. Indeed, at least cases 1 and 8 of Bright's original report and cases 1, 5 and 8 of his second paper in Osman's edition1seem to us instances of hypertension, essential or malignant rather than the characteristic syndrome, glomerulonephritis, which now most characteristically bears...Bibliography1. OSMAN AA Original Papers of RICHARD BRIGHT on Renal Disease., 1937. Oxford University Press, London. Humphrey Milford. 1937. Google Scholar2. SMITHGOLDRINGCHASIS HWWH: The measurement of the tubular excretory mass, effective blood flow and filtration rate in the normal human kidney, Jr. Clin. Invest., 1938, xvii, 263. CrossrefGoogle Scholar3. CORCORANPAGE ACIH: Applications of diphenylamine in the determination of levulose in biological mediums. I. The determination of inulin, Jr. Biol. Chem., 1939, cxxvii, 601. CrossrefGoogle Scholar4. CORCORANPAGE ACIH: The determination of diodrast-iodine in blood and urine, Jr. Lab. and Clin. Med., 1943, xxviii, 1514. Google Scholar5. SMITH HW: The physiology of the kidney, 1937, Oxford University Press, New York. Google Scholar6. SMITHSMITH WWHW: Protein-binding of phenol red, diodrast and other substances in plasma, Jr. Biol. Chem., 1938, cxxiv, 107. CrossrefGoogle Scholar7. WHITEHEINBECKER HLP: Observations on inulin and diodrast clearances and on renal plasma flow in normal and hypophysectomized dogs, Am. Jr. Physiol., 1940, cxxx, 454. CrossrefGoogle Scholar8. CORCORANSMITHPAGE ACHWIH: The removal of diodrast from blood by the dog's explanted kidney, Am. Jr. Physiol., 1941, cxxxiv, 333. CrossrefGoogle Scholar9. SMITH HW: Lectures on the kidney, 1943, University Extension Division, University of Kansas, Lawrence. Google Scholar10. CORCORANPAGE ACIH: Effects of hypotension due to hemorrhage and of blood transfusion on renal function in dogs, Jr. Exper. Med., 1943, lxxviii, 205. CrossrefGoogle Scholar11. CORCORANPAGE ACIH: Renal blood flow in experimental renal hypertension, Am. Jr. Physiol., 1942, cxxxv, 361. Google Scholar12. FOUTSCORCORANPAGE PJACIH: Am. Jr. Med. Sci., 1941, cci, 313. CrossrefGoogle Scholar13. BOBEYLONGLEYDICKESPRICEHAYMAN MELPRJWJM: The effect of uranium poisoning on plasma diodrast clearance and renal plasma flow in the dog, Am. Jr. Physiol., 1943, cxxxix, 155. CrossrefGoogle Scholar14. NICHOLSONURQUHARTSELBY TFRWDL: Renal function as affected by experimental unilateral kidney lesions. I. Nephrosis due to sodium tartrate, Jr. Exper. Med., 1938, lxviii, 439. CrossrefGoogle Scholar15. FINDLEYEDWARDSCLINTONWHITE TJCEHL: Clearance of diodrast, phenolphthalein and inulin in hypertension and in nephritis, Arch. Int. Med., 1942, lxx, 935. CrossrefGoogle Scholar16. SMITH HW: Note on the interpretation of clearance methods in the diseased kidney, Jr. Clin. Invest., 1941, xx, 631. CrossrefGoogle Scholar17. GOLDRINGCHASISRANGESSMITH WHHAHW: Effective renal blood flow in subjects with essential hypertension, Jr. Clin. Invest., 1941, xx, 631. Google Scholar18. CORCORANTAYLORPAGE ACRDIH: Acute toxic nephrosis, Jr. Am. Med. Assoc., 1943, cxxiii, 81. CrossrefGoogle Scholar19. GOLDRINGCHASISRANGESBRADLEYSMITH WHHAJEHW: The application of saturation methods to the study of glomerular and tubular function in the human kidneys, Jr. Mt. Sinai Hosp., 1943, x, 59. Google Scholar20. LAMPORT H: Formulae for afferent and efferent arteriolar resistance in the human kidney: an application to the effects of spinal anesthesia, Jr. Clin. Invest., 1941, xx, 535. CrossrefGoogle Scholar21. LAMPORT H: Improvements in calculation of renal resistance to blood flow. Charts for osmotic pressure and viscosity of blood, Jr. Clin. Invest., 1943, xxii, 461. CrossrefGoogle Scholar22. VAN SLYKESTILLMANMOLLEREHRICHMCINTOSHLEITERMACKAYHANNONMOOREJOHNSTON DDEEWJFLEMRRMC: Observations on the courses of the different types of Bright's disease and on the resultant changes in renal anatomy, Medicine, 1930, ix, 257. CrossrefGoogle Scholar23. CHASISSMITH HHW: The excretion of urea in normal man and in subjects with glomerulonephritis, Jr. Clin. Invest., 1938, xvii, 347. CrossrefGoogle Scholar24. ADDISSHEVKY TE: A test of the capacity of the kidney to produce urine of high specific gravity, Arch. Int. Med., 1922, xxx, 559. CrossrefGoogle Scholar25. ALVINGVAN SLYKE ASDD: The significance of concentration and dilution tests in Bright's disease, Jr. Clin. Invest., 1934, xiii, 969. CrossrefGoogle Scholar26. CORCORANPAGE ACIH: Quantitative formulation of maximum urinary specific gravity, Jr. Mt. Sinai Hosp., 1942, viii, 459. Google Scholar27. HAYMANMARTINMILLER JMJWM: Renal function and the number of glomeruli in the human kidney, Arch. Int. Med., 1939, lxiv, 69. CrossrefGoogle Scholar28. NEWBURGH JD: The changes which alter renal osmotic work, Jr. Clin. Invest., 1943, xxii, 439. CrossrefGoogle Scholar29. MANSFIELDMALLORYELLIS JSGKLB: The differential diagnosis of chronic Bright's disease, New England Jr. Med., 1943, ccxxix, 387. CrossrefGoogle Scholar30. KEITHWAGENERKERNOHAN NWHPJW: Syndrome of malignant hypertension, Arch. Int. Med., 1928, xli, 141. CrossrefGoogle Scholar31. PAGE IH: A clinical study of malignant hypertension, Ann. Int. Med., 1939, xii, 978. Google Scholar32. ADDISOLIVER TJ: The renal lesion in Bright's disease, 1931, Paul B. Hoeber, New York. Google Scholar33. OLIVER J: Architecture of the kidney in chronic Bright's disease, 1939, Paul B. Hoeber, New York. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Indianapolis, Indiana*Received for publication February 3, 1944.From the Lilly Laboratory for Clinical Research, Indianapolis City Hospital, Indianapolis, Indiana. Nextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited bySympathectomy in the treatment of benign and malignant hypertension: A review of 76 patientsBILATERAL NEPHRECTOMY FOR MALIGNANT HYPERTENSIONTreatment and Prognosis in Malignant Hypertension Clinical Follow-up Study of 93 Patients on Modern Medical TreatmentThe natural history and course of hypertension with papilledema (Malignant Hypertension)Malignant HypertensionRenal function in renal diseasesPHYSIOLOGY OF THE DISEASED KIDNEY*Hypertensive Vascular Disease: Its Clinical Course, Differential Diagnosis, Pathogenesis and TreatmentEFFECT OF LARGE DOSES OF ALKALI ON KIDNEY FUNCTION 1 November 1944Volume 21, Issue 5Page: 747-764KeywordsAnemiaClinical laboratoriesGlomerulonephritisHypertensionProteinuriaResearch laboratoriesRetinitisWeight loss ePublished: 1 December 2008 Issue Published: 1 November 1944 Copyright & PermissionsCopyright, 1944, by The American College of PhysiciansPDF downloadLoading ...